Genomic Health, Inc. Turns a Profit (With an Asterisk)

Genomic Health (NASDAQ: GHDX) recorded a $1.1 million profit during the third quarter, something it's been shooting for as it's improved its bottom line for each of the last nine consecutive quarters. But the profit only came on a non-GAAP basis, in which the company subtracted out the expenses associated with its recently announced collaboration with Biocartis. On a GAAP basis, Genomic Health lost a still-reasonable $2.2 million.

Metric

Q3 2017

Continue reading


Source: Fool.com